Skip Ribbon Commands
Skip to main content
Sign In
{{'GLOBAL_MESSAGE_HEADLINE' | translate}}
{{'GLOBAL_MESSAGE_CHOOSE_LANG' | translate}}
en
日本語
中文
{{'GLOBAL_MESSAGE_OR' | translate}}
{{'GLOBAL_MESSAGE_SET_COUNTRY' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM_CLOSE' | translate}}
{{'ELOQUA_BANNER_ACCEPT' | translate}}
{{'ELOQUA_BANNER_DECLINE' | translate}}
NEWS & EVENTS

RECENT NEWS

Automating fill and finish: Five steps for scaling success - 23 November 2021
Top three reasons why automated data acquisition is critical to fill and finish quality - 23 November 2021
Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe - 16 November 2021
Action Center Set to Provide Grocery Boxes for 5,700 Meals This Thanksgiving - 4 November 2021
Mallinckrodt and Terumo Blood and Cell Technologies Announce Positive Recommendations in Australia for Public Funding of UVADEX® for ECP Administration with the THERAKOS® CELLEX® Photopheresis System for Chronic Graft Versus Host Disease in Adults - 28 October 2021
Medical innovation helps treatments reach patients faster - 18 October 2021
Terumo Blood and Cell Technologies is collaborating with BioCentriq to provide technologies and expertise to automate cell and gene therapy manufacturing - 7 October 2021
Terumo Blood and Cell Technologies Grant Supports Blood Donor Education Program About Diversity - 27 September 2021
Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcare - 17 September 2021
Terumo Blood and Cell Technologies announces a new software update for its Finia® Fill and Finish System as the cell and gene therapy industry evolves toward automation - 14 September 2021
Health Canada Approves Mirasol Pathogen Reduction Technology System to Treat Platelets in Plasma - 18 August 2021
Terumo Blood and Cell Technologies and PhotonPharma, Inc. announce collaboration to develop a novel cancer immunotherapy - 11 August 2021
First-of-its-kind study published on the positive health economic impact of overcoming blood shortages to treat maternal bleeding in sub-Saharan Africa - 29 July 2021
The Spectra Optia® Apheresis System from Terumo Blood and Cell Technologies in combination with UVA PIT System can now be used to provide extracorporeal photopheresis immunotherapy - 21 July 2021
Terumo Blood and Cell Technologies Joins Cell and Gene Therapy Catapult Process Analytical Technology (PAT) Consortium - 8 June 2021
Terumo Blood and Cell Technologies announces participation in the Connecting the Dots video series, highlighting advanced medical therapies - 26 April 2021
Blood Centers of America Recognizes Outstanding Partners During the COVID-19 Pandemic With Critical Infusion Award - 21 April 2021
Terumo Blood and Cell Technologies and CSL Plasma Announce Collaboration to Deliver New Plasma Collection Platform - 19 April 2021
Asia Pacific Advanced Therapy Manufacturing & Innovation (ATMI) Grant Winner From Seoul National University College Announced by Terumo Blood and Cell Technologies - 12 April 2021
Terumo Blood and Cell Technologies Grants $50,000 to Support Blood Donor Education Program - 7 January 2021
Convalescent Plasma - An Approach to COVID-19 - 15 December 2020
Lakewood Action Center Set to Provide Grocery Boxes for 5,700 Meals This Thanksgiving - 18 November 2020
Terumo Blood and Cell Technologies Joins Cell Manufacturing Research Initiative to Help Advance Cell Therapy Discoveries - 15 October 2020
Terumo Blood and Cell Technologies to Present at Leading International Event for Regenerative Medicine and Advanced Therapies - 9 October 2020
Swiss Approve Mirasol Pathogen Reduction Technology System to Treat Platelets - 24 September 2020
Terumo Blood and Cell Technologies Announces Advanced Therapy Manufacturing and Innovation (ATMI) Grant 2020 for Asia Pacific - 22 September 2020
Terumo Blood and Cell Technologies Accepting Advancing Apheresis Award 2020 Applications - 18 September 2020
First Lady of Ghana Encourages Healthy Ghanaians to Become Champions of Change and Donate Blood to Save Lives - 7 September 2020
MIPLATE Study Involving Mirasol PRT System - 18 August 2020
Terumo Blood and Cell Technologies’ Mirasol reduces the virus causing COVID-19 below the limit of detection in plasma and platelets - 23 April 2020
Terumo Donates USD 2.4 Million in Cash and Products to Support COVID-19 Pandemic Relief Efforts Worldwide - 22 April 2020
Terumo Blood and Cell Technologies’ Mirasol Shows Efficacy Against Virus Causing COVID-19 in Plasma and Platelets - 17 April 2020
COVID-19 Update on Terumo Blood and Cell Technologies’ Manufacturing in Trivandrum, India (Terumo Penpol) - 26 March 2020
Terumo Blood and Cell Technologies' Lakewood, Colorado Operations and COVID-19 - 24 March 2020
Terumo Blood and Cell Technologies & Business Continuity

More News



EVENTS

{{event.month}}

{{e.Title}} {{e.Title}}

{{e.Location}}, {{convertDate(e.EventStartDate)}} - {{convertDate(e.EventEndDate)}}
Visit our Virtual Events and Congress Portal



​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

{{'SEARCH_MODAL_TITLE' | translate }}
{{'SEARCH_MODAL_OR' | translate }}

{{'SEARCH_MODAL_BROWSE' | translate }} {{'SEARCH_MODAL_ENLABEL' | translate }}
{{'SEARCH_MODAL_CHOOSE_LANGUAGE' | translate }} {{'SEARCH_MODAL_CHANGE_LANGUAGE' | translate }}
{{$index+1}}. {{s.label}}